In antibacterials, the company has demonstrated notable progress in particular in the rapid discovery of unique chemical structures for antibiotics against carbapenem-resistant Gram-negative ...

In this report, we will review recent pharmacokinetic (PK) and PK/pharmacodynamic (PD) findings for the most often used antibiotics against major GNB with acquired resistance to carbapenems.

These are antibiotics that are normally reserved for serious infections in hospitals. Carbapenems are effective against bacteria which have become immune to penicillins and cephalosporins. The ...

Most resistant to carbapenems Gram-negative bacteria isolates are only susceptible to polymyxins, which are commonly the main antibiotic class used against these isolates. Some shortcomings of ...

Increasing incidence of bloodstream infections with Enterobacterales resistant to carbapenem antibiotics poses a significant threat to patients and healthcare systems in the EU/EEA Furthermore ...

Carbapenem-resistant Enterobacterales (CRE ... Even though several new antibiotics are available, treatment options remain limited overall. Immediate action is essential to control this problem ...

Wockhardt Limited announced that its innovative antibiotic, Zaynich (Zidebactam/Cefepime), demonstrated over 97% clinical efficacy in treating serious infections ...